학술논문
Clinical benefit of granulocyte-colony stimulating factor (GCSF) use during chemoimmunotherapy treatment for metastatic pancreatic adenocarcinoma (mPDAC).
Document Type
Article
Author
Lyman, Jaclyn P.; Cabanski, Christopher R; Maddock, Stephen; Wolff, Robert A.; Wainberg, Zev A.; Ko, Andrew H.; Rahma, Osama E.; Fisher, George A.; Gabriel, Peter Edward; Doucette, Abigail; Zheng-Lin, Binbin; Maloy, Molly A.; Dugan, Ute; Fairchild, Justin P.; Spasic, Marko; O'Donnell-Tormey, Jill; Vonderheide, Robert H.; O'Hara, Mark H.; O'Reilly, Eileen Mary
Source
Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p757-757, 1p
Subject
Language
ISSN
0732183X